These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2905034)

  • 1. DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25.
    Graziano SL; Mark GE; Murray C; Mann DL; Ehrlich GD; Poiesz BJ; Weston A
    Oncogene Res; 1988; 3(1):99-103. PubMed ID: 2905034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at the c-raf locus in small cell lung carcinoma.
    Sithanandam G; Dean M; Brennscheidt U; Beck T; Gazdar A; Minna JD; Brauch H; Zbar B; Rapp UR
    Oncogene; 1989 Apr; 4(4):451-5. PubMed ID: 2566144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin 4 (MUC4) gene: regional assignment (3q29) and RFLP analysis.
    Gross MS; Guyonnet-Duperat V; Porchet N; Bernheim A; Aubert JP; Nguyen VC
    Ann Genet; 1992; 35(1):21-6. PubMed ID: 1351710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single point mutation responsible for c-mos polymorphism in cancer patients.
    Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed genetic mapping of the A-raf proto-oncogene on the mouse X chromosome.
    Grant SG; Chapman VM
    Oncogene; 1991 Mar; 6(3):397-402. PubMed ID: 2011396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancer.
    Graziano SL; Pfeifer AM; Testa JR; Mark GE; Johnson BE; Hallinan EJ; Pettengill OS; Sorenson GD; Tatum AH; Brauch H
    Genes Chromosomes Cancer; 1991 Jul; 3(4):283-93. PubMed ID: 1683566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of three biallelic restriction fragment length polymorphisms versus a polymorphic dinucleotide tandem repeat polymorphism at the low-density-lipoprotein receptor gene locus for diagnosis of familial hypercholesterolemia.
    Weiss N; Gudnasson V; Ostwald P; Humphries S; Schuster H; Keller C
    Dis Markers; 1997 Nov; 13(3):141-51. PubMed ID: 9405927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
    Knowles MA; Shaw ME; Proctor AJ
    Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close proximity of c-erbA2 and c-erbA-beta genes on the short arm of chromosome 3.
    Ali IU; Saxena A; Meissner S; Barrick J; Lidereau R
    Oncogene; 1993 Aug; 8(8):2299-301. PubMed ID: 8393165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12.
    Opdenakker G; Fiten P; Nys G; Froyen G; Van Roy N; Speleman F; Laureys G; Van Damme J
    Genomics; 1994 May; 21(2):403-8. PubMed ID: 7916328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cDNA probe (PheA12) from the hc-(ERBA) gene on chromosome 3 detects a high frequency RFLP.
    Bale AE; Usala S; Weinberger C; Weintraub BD; McBride OW
    Nucleic Acids Res; 1988 Aug; 16(15):7756. PubMed ID: 2901070
    [No Abstract]   [Full Text] [Related]  

  • 12. [Strategies for detecting restriction polymorphisms of Y chromosome sequences].
    Ngo KY; Lucotte G
    Ann Genet; 1986; 29(2):88-92. PubMed ID: 2876675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal localization of the human urothelial "tetraspan" gene, UPK1B, to 3q13.3-q21 and detection of a TaqI polymorphism.
    Finch JL; Webb GC; Evdokiou A; Cowled PA
    Genomics; 1997 Mar; 40(3):501-3. PubMed ID: 9073521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
    Trench GC; Southall M; Smith P; Kidson C
    Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
    Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
    Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic polymorphism and susceptibility to cancer].
    Larsen CJ
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus.
    Teyssier JR; Henry I; Dozier C; Ferre D; Adnet JJ; Pluot M
    J Natl Cancer Inst; 1986 Dec; 77(6):1187-95. PubMed ID: 3467112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
    Liu WH; Kaur M; Makrigiorgos GM
    Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RFLP for the human erb-A beta locus.
    Wyllie FS; Lazarou LP; Wynford-Thomas D
    Nucleic Acids Res; 1988 Jun; 16(11):5224. PubMed ID: 2898764
    [No Abstract]   [Full Text] [Related]  

  • 20. The X chromosome shows less genetic variation at restriction sites than the autosomes.
    Hofker MH; Skraastad MI; Bergen AA; Wapenaar MC; Bakker E; Millington-Ward A; van Ommen GJ; Pearson PL
    Am J Hum Genet; 1986 Oct; 39(4):438-51. PubMed ID: 2876629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.